Treatment of seizures and epilepsy in children and adolescents

Neurology

Volumn 51, Issue 5 SUPPL. 4, 1998, Pages

  Pellock, John M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CORTICOTROPIN; ETHOSUXIMIDE; FELBAMATE; GABAPENTIN; GLUCOCORTICOID; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ABSENCE; ADOLESCENT; BENIGN CHILDHOOD EPILEPSY; CHILD; CONFERENCE PAPER; DOSE RESPONSE; DRUG CHOICE; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; ELECTROENCEPHALOGRAM; FEBRILE CONVULSION; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; INFANTILE SPASM; LENNOX GASTAUT SYNDROME; MYOCLONUS SEIZURE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SEIZURE; SIDE EFFECT; TONIC CLONIC SEIZURE;

EID: 0031738597     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.51.5_suppl_4.s8     Document Type: Conference Paper

References (61)

1. Pellock JM. Seizures and epilepsy in infancy and childhood. Neurol Clin 1993;11:755-775.
2. Morton LD, Pellock JM. Diagnosis and treatment of epilepsy in children and adolescents. Drugs 1996;51:399-414.
3. Glaze DG, Hrachovy RA, Frost JD, et al. Prospective study of outcome of infants with infantile spasms treated during controlled studies of ACTH and prednisone. J Pediatr 1988;112: 389-396.
4. Snead OC. ACTH and steroids. In: Dodson WE, Pellock JM, eds. Pediatric epilepsy: diagnosis and therapy. New York: Demos, 1993:331-336.
5. Aicardi J, Mumford JP, Dumas C, Wood S. Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabris IS Investigator and Peer Review Groups. Epilepsia 1996;37:638-642.
6. Vigevano F, Cilio MR, Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study. Epilepsia 1997;38:1270-1274.
7. Chiron C, Dulac O, Beaumont D, et al. Therapeutic trial of vigabatrin in refractory infantile spasms. J Child Neurol 1991; 6(suppl 2):S252-S256.
8. Siemes H, Spohr HL, Michael TH, et al. Therapy of infantile spasms with valproate: results of a prospective study. Epilepsia 1988;29:553-560.
9. Prats JM, Garaizar C, Rua MJ, et al. Infantile spasms treated with high doses of sodium valproate: initial response and follow-up. Dev Med Child Neurol 1991;33:617-625.
10. Dreifuss F, Farwell J, Holmes G, et al. Comparative trial of nitrazepam and corticotrophin. Arch Neurol 1986;43:1107-1110.
11. Farrell K. Benzodiazepines in the treatment of children with epilepsy. Epilepsia 1986;27(suppl 1):S45-S51.
12. O'Donohoe NV, Paes BA. A trial of clonazepam in the treatment of severe epilepsy in infancy and childhood. In: Penry JK, ed. Epilepsia: the VIIIth International Symposium. New York: Raven Press, 1977:159-162.
13. Robertson MM. Current status of the 1,4- and 1,5-benzodiazepines in the treatment of epilepsy: the place of clobazam. Epilepsia 1986;27(suppl 1):S27-S41.
14. Veggiotti P, Cieuta C, Rex E, et al. Lamotrigine in infantile spasms [letter]. Lancet 1994;344:1375-1376.
15. Espe-Lillo J, Ritter FJ, Frost MD. Safety and efficacy of felbamate in treatment of infantile spasms [abstract]. Epilepsia 1993;34(suppl 6):110.
16. Hurst DL, Rolan TD. The use of felbamate to treat infantile spasms. J Child Neurol 1995;10:134-136.
17. Glauser TA, Clark P, Strawsburg R. Topiramate in subjects with infantile spasms: a pilot study. Epilepsia 1997;38:96-97.
18. Hosain S, Nagarajan L, Carson D, Solomon G, Mast J, Labar D. Felbamate for refractory infantile spasms. J Child Neurol 1997;12:466-468.
19. Chugani HT, Shields D, Shewman DA, et al. Infantile spasms: I. PET identifies local cortical dysplasia in cryptogenic cases for surgical treatment. Ann Neurol 1990;27:406-413.
20. Shields D, Sherman A, Chugan HT, et al. Treatment of infantile spasms: medical or surgical? Epilepsia 1992;33(suppl 4): 26-31.
21. Asarnow RF, LoPresti C, Guthrie D, et al. Developmental outcomes in children receiving resection surgery for medically intractable infantile spasms. Dev Med Child Neurol 1997;39: 430-440.
22. Hrachovy RA, Frost JD. Severe encephalopathic epilepsy in infants: infantile spasms. In: Dodson WE, Pellock JM, eds. Pediatric epilepsy: diagnosis and therapy. New York: Demos, 1993;135-146.
23. Willmore LJ, Triggs WJ, Pellock JM. Valproate toxicity: risk-screening strategies. J Child Neurol 1991;6:3-6.
24. Snead OC 3d, Hosey LC. Exacerbation of seizures in children by carbamazepine. N Engl J Med 1985;313:916-921.
25. Swink TD, Vining EP, Freeman JM. The ketogenic diet: 1997. Adv Pediatr 1997;44:297-329.
26. The Felbamate Study Group in Lennox-Gastaut syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993;328:29-33.
27. Motte J, Trevathan E, Arvidsson JFV, et al. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. N Engl J Med 1997;337:1807-1812.
28. French JA, Bourgeois BFD, Dreifuss FE, et al. An open-label multicenter study of topiramate in patients with the Lennox-Gastaut syndrome [abstract]. Neurology 1995;45(suppl 4): A250.
29. Appleton RE. The role of vigabatrin in the management of infantile epileptic syndromes. Neurology 1993;43(suppl 5): S21-S23.
30. Dulac O, Kaminska A. Use of lamotrigine in Lennox-Gastaut and related epilepsy syndromes. J Child Neurol 1997;12(suppl 1):S23-S28.
31. Dreifuss FE. Lamotrigine in childhood epilepsies. Semin Pediatr Neurol 1997;4:19-22.
32. Ritter FJ, Glauser TA, Sachdeo RC, Wu SC, and the YL Study Group. Topiramate as long-term therapy in Lennox-Gastaut syndrome [abstract]. Neurology 1998;50(suppl 4):A312.
33. Marciani MG, Maschio M, Spanedda F, et al. Development of myoclonus in patients with partial epilepsy during treatment with vigabatrin: an electroencephalographic study. Acta Neurol Scand 1995;91:1-5.
34. Gherpelli JL, Guerreiro MM, daCosta JC, et al. Vigabatrin in refractory childhood epilepsy: the Brazilian Multicenter Study. Epilepsy Res 1997;29:1-6.
35. Theodore WH. Felbamate. In: Engel K, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven, 1997;1509-1514.
36. Garnett WR. Lamotrigine: pharmacokinetics. J Child Neurol 1997;12(suppl 1):S10-S15.
37. Glauser TA. Topiramate. Semin Pediatr Neurol 1997;4:34-42.
38. Davis R, Peters DH, McTavish D. Valproic acid: a reappraisal of its pharmacological properties and clinical efficacy in epilepsy. Drugs 1994;47:332-372.
39. Verity CM, Hosking G, Easter DJ. A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy: the Paediatric EPITEG Collaborative Group. Dev Med Child Neurol 1995;37:97-108.
40. Perrucca E. Recipes for clinical practice. In: Trimble MR, ed. New anticonvulsants: advances in the treatment of epilepsy. Chichester: John Wiley and Sons, 1994;145-162.
41. Heller AJ, Stewart J, Hughes E, et al. Comparative efficacy and toxicity of phenobarbital, phenytoin, carbamazepine, and valproate in adults and children with newly diagnosed, previously untreated epilepsy: a randomized long-term trial [abstract]. Epilepsia 1993;34(suppl 2):66.
42. Meador KJ, Loring DW, Hugh K, et al. Comparative cognitive effects of anticonvulsants. Neurology 1990;40:391-394.
43. Trimble MR. Behavioral and cognitive issues in childhood epilepsy. In: Dodson WE, Pellock JM, eds. Pediatric epilepsy: diagnosis and therapy. New York: Demos, 1993;387-407.
44. Watemberg N, Pellock JM. Efficacy and tolerance of long term, high-dose gabapentin add-on therapy in children and adults [abstract]. Epilepsia 1995;36(suppl 4):57.
45. Alehan FK, Watemberg NM, Pellock JM. The correlation between gabapentin serum levels and doses in children [abstract]. Epilepsia 1997;38:93.
46. Shinnar S. Tiagabine. Semin Pediatr Neurol 1997;4:24-33.
47. Khurana DS, Riviello J, Helmers S, Holmes G, Anderson J, Mikati MA. Efficacy of gabapentin therapy in children with refractory partial seizures. J Pediatr 1996;128:829-833.
48. Elwes RDC, Johnson AL, Shorvon SD, et al. The prognosis for seizure control in newly diagnosed epilepsy. N Engl J Med 1984;311:944-947.
49. Rosman NP, Colton T, Labazzo J, et al. A controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile seizures. N Engl J Med 1993;329:79-84.
50. Pellock JM. Management of acute seizure episodes. Epilepsia 1998;39(suppl 1):S28-S35.
51. Morton LD, Rivkallah E, Pellock JM. New drug therapy for acute seizure management. Semin Pediatr Neurol 1997;4: 51-63.
52. Henriksen O. An overview of benzodiazepines in seizure management. Epilepsia 1998;39(suppl 1):S2-S6.
53. Pellock JM, Pippinger CE. Adverse effects of antiepileptic drugs. In: Dodson WE, Pellock JM, eds. Pediatric epilepsy: diagnosis and therapy. New York: Demos, 1993;253-263.
54. Wolf SN, Shinnar S, Kang H, et al. Gabapentin toxicity manifesting as behavioral changes. Epilepsia 1996;36:1203-1205.
55. Pellock JM. Overview of lamotrigine and the new antiepileptic drugs: the challenge. J Child Neurol 1997;12(suppl 1):S48-S52.
56. Messenheimer J, Ramsay RE, Willmore LJ, et al. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, crossover trial. Epilepsy 1994;35:113-121.
57. Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy: UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet 1995;345:476-479.
58. Pellock JM, Brodie MJ. Felbamate: 1997 update. Epilepsia 1997;38:1261-1264.
59. Seetharam MN, Pellock JM. Risk-benefit assessment of carbamazepine in children. Drug Saf 1991;6:148-158.
60. Kaufman DW, Kelly JP, Anderson T, Harmon DC, Shapiro S. Evaluation of case reports of aplastic anemia among patients treated with felbamate. Epilepsia 1997;38:1265-1269.
61. Massey GV, Dunn NL, Heckel JL, Myer EC, Russell EC. Aplastic anemia following therapy for absence seizures with ethosuximide. Pediatr Neurol 1994;11:59-61.